-
Healthy eating during the COVID-19 pandemic: Your eating habits
Healthy eating is more than the foods you eat. It is also about where, when, why and how you eat. -
Regulatory Initiative: Regulations Supporting the Proposed Cannabis Act -...
Consultation on the Proposed Approach to the Regulation of Cannabis. -
Hard-surface disinfectants and hand sanitizers (COVID-19): List of...
Health Canada has developed the following list of hard-surface disinfectants that are likely to be effective and may be used against SARS-CoV-2, the coronavirus that causes... -
Testing devices for COVID-19: Antigen testing devices
The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices. -
Food security
Discover how Canada determines food security status. Also learn about the Household Food Security Survey Module used to measure food security status. -
Health Product InfoWatch – March 2022
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals. -
Summary Safety Review - Codeine-containing products - Further Assessing the...
In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of potentially life-threatening breathing problems. At the... -
Cannabis voluntary recall guide
This guide provides information on the requirements of the Cannabis Act and Cannabis Regulations related to voluntary recalls of cannabis and cannabis products. -
Insulin Pumps
An insulin pump is a medical device used by people with diabetes. It's an alternative to multiple daily injections of insulin using a syringe or pen. -
Good manufacturing practices and COVID-19
Good manufacturing practices (GMP) ensure that drugs meet the quality standards appropriate to their intended use before they are sold. -
Sodium Intake of Canadians in 2017
In 2010, Canada's federal, provincial and territorial ministers of health agreed on the goal to reduce the average sodium intake of Canadians by a third, from 3400 mg to 2300 mg... -
Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health Products
Health Canada has implemented the International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance: E2D Post-Approval Safety... -
Notice: Guidance Document – Requirements in the Recognition Process for...
This guidance document provides medical device stakeholders with information on the requirements that the Therapeutics Products Directorate will use in recognizing Auditing... -
Poly(amines) Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 9 substances referred to collectively as the... -
Notice - Prescription Drug List (PDL): Polymyxin B
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Polymyxin B to prescription status for... -
Radiation Protection in Mammography: Recommended Safety Procedures for the...
Diagnostic X-ray imaging is an essential part of present day medical practice. However, mammographic X-ray procedures must be carefully managed, because X-radiation has the... -
Natural Health Product Licence Amendment and Notification Form User Guide
The Amendment and Notification Form (ANF) is the exclusive form to be used for submitting post licensing changes for a licensed natural health product (NHP) to the Natural and... -
Federal Contaminated Site Risk Assessment in Canada: Supplemental Guidance...
This guidance document was prepared to provide guidance for custodial departments. -
Draft guidance on improving indoor air quality in office buildings:...
The IAQ resolution process will often involve responding to a reported air quality issue. Occupants may report concerns through the supervisor or manager, the health and safety...